7-Chloro-2,3-dihydro-1,8-naphthyridin-4(1H)-one, 95.0%, 250mg

Naphth-1-ylacetyl chloride, 95.0%, 250mg

4-(4-Bromophenyl)piperidin-4-ol hydrochloride, 98%, 5g

Ethyl 2-amino-6-fluoro-3-methylbenzoate, 98%, 500mg

2-(Bromomethyl)-5-(trifluoromethyl)pyridine, 95.0%, 100mg

2-(2-((4-(5-Chloro-2-methylphenyl)piperazinyl)carbonyl)phenyl)acetic acid, 98%, 98.0%, 10g

1-(4-Fluoro-2-nitrophenyl)piperidine-4-carboxylic acid, 95.0%, 1g

Monomethacryloxypropylterminated polydimethylsiloxane - asymmetric cSt 150-200 inhibited with BHT, 100g

D(+)-Saccharose, 100 g

2,3,6-Trifluorophenylacetonitrile, 97.0%, 5g

2-Bromo-1,3-diisopropylbenzene, 95.0%, 25g

N-(4-METHOXY-PHENYL)-2-METHYL-ACRYLAMIDE, 90.0%, 500mg

Methyl 4-bromo-3-methoxybenzoate, 95.0%, 10g